3 ms·
With the current CAR-T technology, you’re “turning on” the T-cell so it attacks certain cell types. You only need a few of those cells as they can multiply wit
by refurb 8y ago
With the current CAR-T technology, you’re “turning on” the T-cell so it attacks certain cell types. You only need a few of those cells as they can multiply within the body.
What you’re talking about is the opposite, turning the T cell “off”. You’d also need to do that to every T cell or alternatively, destroy every T cell and restart with a batch of new cells.
Very different problems.
- WalterSear 8y agoOr program the T-cells to attack mesenchymal cells that are producing the defective ones. I'd wager that the process would still be much more difficult than targeting cancerous cells, and certainly be very complicated. But, there's hope for other diseases, though the article is focused on cancer: > Not only can this technology help revolutionize TCR-T cell therapies for cancer, but it will also be a powerful tool for discovering other immunological agents, including antibodies and CAR-T cells, and for elucidating new immunology and cancer biology at a depth not possible before.